Your session is about to expire
← Back to Search
Peer Navigation for Serious Mental Illness After Jail Release
N/A
Recruiting
Research Sponsored by Michigan State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Aged 18 or above
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 months and 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial proposes developing a peer-navigator intervention to help incarcerated individuals with serious mental illness access community-level mental health & medical care services after release.
Who is the study for?
This trial is for adults in Genesee County Jail with serious mental illness (like schizophrenia, bipolar disorder, or major depression with psychosis) who are getting out in the next two months. They must be able to provide contacts for follow-up and have access to a phone. It's not for those going straight to prison after jail.
What is being tested?
The study is testing a 'peer navigation intervention' designed to help individuals with serious mental illness connect better with community services like mental health care, medical treatment, and substance use programs after they leave jail.
What are the potential side effects?
Since this trial involves social support rather than medication, traditional side effects aren't expected. However, participants may experience emotional discomfort or stress during the re-entry process which the peer navigation aims to mitigate.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, three months and six months.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, three months and six months.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Acceptability: Client Satisfaction Questionnaire
Acceptability: End of treatment
Feasibility: Client Satisfaction
+1 moreSecondary study objectives
Clinical outcomes
Life context outcomes
Service linkage outcomes
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Peer navigationExperimental Treatment1 Intervention
Those who are assigned to the intervention arm will receive peer navigation service by a trained peer navigator who will link them with mental health, medical and substance use services in the community.
Group II: Standard of CareActive Control1 Intervention
SOC consists of TAU + monitoring and emergency referral, as is required to fulfil ethical obligations to trial participants. To determine the naturalistic effects and costs of adding peer navigation intervention, participants in both conditions can receive any other treatment available to them and we will not exclude participants receiving other treatment. We will carefully characterize TAU for each condition as part of our service utilization assessment.
Find a Location
Who is running the clinical trial?
Michigan State UniversityLead Sponsor
198 Previous Clinical Trials
685,715 Total Patients Enrolled
Brown UniversityOTHER
466 Previous Clinical Trials
699,040 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Standard of Care
- Group 2: Peer navigation
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.